Literature DB >> 34724861

Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment.

Qi Li1, Jinhao Hu1, Yibo Shi1, Mulun Xiao1, Tianxiang Bi1, Chaoliang Wang1, Liang Yan1, Xiaoyan Li2.   

Abstract

Exosomes mediate the interaction between cancer cells and their microenvironment, and play a key role in tumor development. Although exosomes can package lncRNAs to mediate extracellular communication, the role of exosomal lncRNA AY927529 in prostate cancer (PCa) remains unclear. Exosomes were extracted from normal human prostatic epithelial cell lines (BPH-1 and RWPE-1) and PCa cell lines (VCaP and LNCaP, DU145, PC3) by ultrahigh speed centrifugation. Results of Western blot indicated that Alix, HSC70 and TSGl01 protein levels were upregulated in exosomes derived from PCa cells. LncAY927529 level was upregulated in PCa cells and exosomes derived from PCa patient serum and human PCa cells. CCK-8, Transwell and Flow cytometry assays demonstrated that bone marrow stromal cell line (ST2) conditioned medium (ST2-CM), treated with exosomes derived from PCa cells with high lncAY927529 level, promoted proliferation and invasion of PC3 and DU145 cells, and inhibited cell apoptosis. RT-qPCR assay indicated that lncAY927529 level was downregulated in PC3 and DU145 cells, exosomes derived from PCa cells (PCa-Exo) and ST2-CM treated with PCa-Exo with low expression of lncAY927529, and overexpression of lncAY927529 had the opposite results. In addition, Western blot assay showed that the autophagy related protein LC3II level was increased in ST2 cells treated with exosomes derived from DU145 cells with high expression of lncAY927529, and LC3I protein level was decreased. CXCL14 acted as a RNA-binding protein of lncAY927529, and exosome-mediated lncAY927529 positively regulated CXCL14 levels in ST2 cells. In general, exosome-mediated lncAY927529 could promote PCa cell proliferation and invasion by regulating bone microenvironment, suggesting that exosomal lncAY927529 may be a potential molecular diagnostic marker of PCa.

Entities:  

Keywords:  Prostate cancer; apoptosis; autophagy; exosomes; lncAY927529

Mesh:

Substances:

Year:  2021        PMID: 34724861      PMCID: PMC8794529          DOI: 10.1080/15384101.2021.1992853

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  36 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 2.  [Chemokines and tumors].

Authors:  Antonio Pellegrino; Angelo Vacca; Claudio Scavelli; Franco Dammacco
Journal:  Recenti Prog Med       Date:  2002-11

3.  A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods.

Authors:  David W Greening; Rong Xu; Hong Ji; Bow J Tauro; Richard J Simpson
Journal:  Methods Mol Biol       Date:  2015

Review 4.  Exosomes.

Authors:  D Michiel Pegtel; Stephen J Gould
Journal:  Annu Rev Biochem       Date:  2019-06-20       Impact factor: 23.643

5.  Emerging Role of Mesenchymal Stem Cell-derived Exosomes in Regenerative Medicine.

Authors:  Ting Zhao; Feng Sun; Jinwen Liu; Tianyan Ding; Jie She; Fei Mao; Wenrong Xu; Hui Qian; Yongmin Yan
Journal:  Curr Stem Cell Res Ther       Date:  2019       Impact factor: 3.828

Review 6.  Autophagy and innate immunity: Insights from invertebrate model organisms.

Authors:  Cheng-Ju Kuo; Malene Hansen; Emily Troemel
Journal:  Autophagy       Date:  2018-02-17       Impact factor: 16.016

Review 7.  Exosome mediated communication within the tumor microenvironment.

Authors:  Lara Milane; Amit Singh; George Mattheolabakis; Megha Suresh; Mansoor M Amiji
Journal:  J Control Release       Date:  2015-07-02       Impact factor: 9.776

8.  ROS-induced autophagy regulates porcine trophectoderm cell apoptosis, proliferation, and differentiation.

Authors:  Zhen Luo; Xue Xu; Takami Sho; Jing Zhang; Weina Xu; Jianbo Yao; Jianxiong Xu
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-28       Impact factor: 4.249

9.  A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.

Authors:  Kendra A Williams; Minnkyong Lee; Ying Hu; Jonathan Andreas; Shashank J Patel; Suiyuan Zhang; Peter Chines; Abdel Elkahloun; Settara Chandrasekharappa; J Silvio Gutkind; Alfredo A Molinolo; Nigel P S Crawford
Journal:  PLoS Genet       Date:  2014-11-20       Impact factor: 5.917

10.  Exosomal LncRNA LBX1-AS1 Derived From RBPJ Overexpressed-Macrophages Inhibits Oral Squamous Cell Carcinoma Progress via miR-182-5p/FOXO3.

Authors:  Yilong Ai; Haigang Wei; Siyuan Wu; Zhe Tang; Xia Li; Chen Zou
Journal:  Front Oncol       Date:  2021-03-17       Impact factor: 6.244

View more
  3 in total

Review 1.  The diagnostic role and mechanistic functions of exosomal lncRNAs in prostate cancer.

Authors:  Hangsheng Zhou; Hongyuan Wan; Yanyan Feng; Lijie Zhu; Yuanyuan Mi
Journal:  Clin Transl Oncol       Date:  2022-10-20       Impact factor: 3.340

Review 2.  Molecular mechanisms and clinical applications of exosomes in prostate cancer.

Authors:  Xiaolin Cui; Qiang Fu; Xueying Wang; Pengcheng Xia; Xianglun Cui; Xiaohui Bai; Zhiming Lu
Journal:  Biomark Res       Date:  2022-07-29

Review 3.  Roles of exosomes as drug delivery systems in cancer immunotherapy: a mini-review.

Authors:  Zhen Fang; Yixuan Ding; Zhigang Xue; Peijuan Li; Jia Li; Fei Li
Journal:  Discov Oncol       Date:  2022-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.